1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK

Publication | Closed Access

DOI

Citations

References

2021

Year

S-E. Al-Batran, Sylvie Lorenzen, Nils Homann, Peter Thuss‐Patience, Michael Schenk, Udo Lindig, A. Kretzschmar, Vera Heuer, Eray Goekkurt, Georg Martin Haag,

Annals of Oncology

Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyDante TrialMedicineGerman Gastric GroupGastroenterologyPathologySurgeryGastrointestinal PathologyUpper Gastrointestinal SurgeryOncologyPathological RegressionCancer ResearchDigestive System Diseases